Five cases of hyperthyroidism in type I diabetic patients treated with intraperitoneal insulin infusion

Safety and glycemic outcomes of DBLG1 coupled to the DANA-i pump in adults and adolescents with type 1 diabetes mellitus. The SP8 trial.

Journal of endocrinological investigation·2025

Practical implementation of automated insulin delivery systems in 2025: A French position statement update.

Diabetes & metabolism·2025

Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study.

Diabetes & metabolism·2021

Impact of moderate exercise on fatty acid oxidation in pancreatic β-cells and skeletal muscle.

Journal of endocrinological investigation·2021

Practical implementation of automated closed-loop insulin delivery: A French position statement.

Diabetes & metabolism·2020

Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: systematic review using a discounting approach.

The Journal of hospital infection·2020

SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.

Diabetes care·2026

β-Cell Dysfunction Identifies Individuals With Single Autoantibody Positivity at Increased Risk of Type 1 Diabetes Progression.

Diabetes care·2026

Comparative Short-term Risk of Severe Gastrointestinal Events Associated With Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists.

Diabetes care·2026

The Minimum Frequency of Well-Day Capillary Blood Ketone Testing Needed to Predict 1-Month Diabetic Ketoacidosis Risk in Type 1 Diabetes.

Diabetes care·2026

Effects of the DASH4D Diet on Biomarkers of Glycemia in Adults With Type 2 Diabetes: A Secondary Analysis of the DASH4D Randomized Clinical Trial.

Diabetes care·2026

Third-Trimester Energy-Restriction or Weight Loss and Maternal and Child Body Composition One Year Postnatally After a Pregnancy With Gestational Diabetes: Results From the DiGest Follow-up Study.

Diabetes care·2026

Reversing Dysfunction of CCR9+ Regulatory T Cells by Targeting the IL-21/IL-17 Axis Improves Type 1 Diabetes.

Diabetes, metabolic syndrome and obesity : targets and therapy·2026

The Patient With Multiple Alloantibodies: A Systematic Strategy for Antibody Identification and Transfusion Management.

Case reports in immunology·2026

Efficacy and safety of bispecific antibodies versus other antitumor therapies in solid tumors: a systematic review and meta-analysis.

Frontiers in immunology·2026

Global development of bispecific antibodies in oncology: a bibliometric analysis of geographic disparities, collaborative models, and emerging translational strategies.

Frontiers in immunology·2026

Quality improvement project - Implementation of subcutaneous immunoglobulin in patients with haematological disorders and secondary immunodeficiency.

Therapeutic advances in hematology·2026

Development of immune-related adverse events is associated with improved survival outcomes in cancer patients receiving immune checkpoint inhibitors.

Frontiers in immunology·2026

Related Experiment Videos

Five cases of hyperthyroidism in type I diabetic patients treated with intraperitoneal insulin infusion

Related Concept Videos

Safety and glycemic outcomes of DBLG1 coupled to the DANA-i pump in adults and adolescents with type 1 diabetes mellitus. The SP8 trial.

Practical implementation of automated insulin delivery systems in 2025: A French position statement update.

Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study.

Impact of moderate exercise on fatty acid oxidation in pancreatic β-cells and skeletal muscle.

Practical implementation of automated closed-loop insulin delivery: A French position statement.

Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: systematic review using a discounting approach.

SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.

β-Cell Dysfunction Identifies Individuals With Single Autoantibody Positivity at Increased Risk of Type 1 Diabetes Progression.

Comparative Short-term Risk of Severe Gastrointestinal Events Associated With Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists.

The Minimum Frequency of Well-Day Capillary Blood Ketone Testing Needed to Predict 1-Month Diabetic Ketoacidosis Risk in Type 1 Diabetes.

Effects of the DASH4D Diet on Biomarkers of Glycemia in Adults With Type 2 Diabetes: A Secondary Analysis of the DASH4D Randomized Clinical Trial.

Third-Trimester Energy-Restriction or Weight Loss and Maternal and Child Body Composition One Year Postnatally After a Pregnancy With Gestational Diabetes: Results From the DiGest Follow-up Study.

Reversing Dysfunction of CCR9+ Regulatory T Cells by Targeting the IL-21/IL-17 Axis Improves Type 1 Diabetes.

The Patient With Multiple Alloantibodies: A Systematic Strategy for Antibody Identification and Transfusion Management.

Efficacy and safety of bispecific antibodies versus other antitumor therapies in solid tumors: a systematic review and meta-analysis.

Global development of bispecific antibodies in oncology: a bibliometric analysis of geographic disparities, collaborative models, and emerging translational strategies.

Quality improvement project - Implementation of subcutaneous immunoglobulin in patients with haematological disorders and secondary immunodeficiency.

Development of immune-related adverse events is associated with improved survival outcomes in cancer patients receiving immune checkpoint inhibitors.

Related Experiment Videos

Five cases of hyperthyroidism in type I diabetic patients treated with intraperitoneal insulin infusion

Related Concept Videos

Related Articles